Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes

Steven P. Marso, Stephen C. Bain, Agostino Consoli, Freddy G. Eliaschewitz, Esteban Jódar, Lawrence A. Leiter, Ildiko Lingvay, Julio Rosenstock, Jochen Seufert, Mark Warren, Vincent Woo, Oluf H. Hansen, Anders G. Holst, Jonas Pettersson, Tina Vilsbøll

New England Journal of Medicine, 2016

Research Medical Center, Swansea University, University of Chieti-Pescara, Hospital Israelita Albert Einstein, Universidad Europea de Madrid, St. Michael's Hospital, University of Toronto, Southwestern Medical Center, The University of Texas Southwestern Medical Center, Dallas Diabetes Research Center, University Medical Center Freiburg, University of Freiburg, Physicians East, University of Manitoba, Novo Nordisk (Finland), University of Copenhagen, Gentofte Hospital

View Free PDF Publisher Website

Abstract

This research paper explore the methodology and findings associated with New England Journal of Medicine. The study delves into the core aspects of the research field, providing significant data and citation impact. (Full abstract processing is available via the OpenAlex API).

6379

Citations

View on Google Scholar

Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes

Abstract

Journal Details

Join JournalsHub

Welcome Back